Wealth Enhancement Advisory Services’s Fidelity Disruptive Medicine ETF FMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.5M | Buy |
688,750
+76,538
| +13% | +$1.84M | 0.03% | 477 |
|
|
2025
Q1 | $14.5M | Buy |
612,212
+28,597
| +5% | +$675K | 0.03% | 492 |
|
|
2024
Q4 | $14.4M | Buy |
583,615
+43,788
| +8% | +$1.08M | 0.03% | 461 |
|
|
2024
Q3 | $14.2M | Buy |
539,827
+19,240
| +4% | +$506K | 0.03% | 428 |
|
|
2024
Q2 | $12.5M | Buy |
520,587
+23,730
| +5% | +$571K | 0.03% | 425 |
|
|
2024
Q1 | $12.7M | Buy |
496,857
+29,339
| +6% | +$749K | 0.03% | 410 |
|
|
2023
Q4 | $11.3M | Buy |
467,518
+1,532
| +0.3% | +$37.1K | 0.03% | 401 |
|
|
2023
Q3 | $10.3M | Buy |
+465,986
| New | +$10.3M | 0.03% | 400 |
|